PYLORI-CHEK BREATH TEST Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pylori-chek Breath Test, and when can generic versions of Pylori-chek Breath Test launch?
Pylori-chek Breath Test is a drug marketed by Dxs Devices and is included in one NDA.
The generic ingredient in PYLORI-CHEK BREATH TEST is urea c-13. There are thirty-three drug master file entries for this compound. Additional details are available on the urea c-13 profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PYLORI-CHEK BREATH TEST?
- What are the global sales for PYLORI-CHEK BREATH TEST?
- What is Average Wholesale Price for PYLORI-CHEK BREATH TEST?
Summary for PYLORI-CHEK BREATH TEST
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Clinical Trials: | 138 |
| Patent Applications: | 120 |
| DailyMed Link: | PYLORI-CHEK BREATH TEST at DailyMed |
Recent Clinical Trials for PYLORI-CHEK BREATH TEST
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Samsung Medical Center | PHASE4 |
| The First Affiliated Hospital with Nanjing Medical University | PHASE4 |
| First People's Hospital of Hangzhou | PHASE4 |
US Patents and Regulatory Information for PYLORI-CHEK BREATH TEST
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dxs Devices | PYLORI-CHEK BREATH TEST | urea c-13 | FOR SOLUTION;ORAL | 020900-001 | Feb 4, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
